UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors

Peter E. Zage, Natalie Sirisaengtaksin, Yin Liu, Monica Gireud, Brandon S. Brown, Shana Palla, Kristen N. Richards, Dennis P.M. Hughes, Andrew J. Bean

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences